Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
第一作者:
Wenhao,Wu
第一单位:
Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, Guangdong, China. wenhao_wu@gzhmu.edu.cn.
作者:
主题词
乙酰胆碱酯酶(Acetylcholinesterase);阿尔茨海默病(Alzheimer Disease);淀粉样β肽类(Amyloid beta-Peptides);抗氧化剂(Antioxidants);结合部位(Binding Sites);催化域(Catalytic Domain);胆碱酯酶抑制剂(Cholinesterase Inhibitors);药物设计(Drug Design);人类(Humans);动力学(Kinetics);吡嗪类(Pyrazines);构效关系(Structure-Activity Relationship)
DOI
10.3390/molecules23102540
PMID
30301153
发布时间
2018-12-12
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文